Worldwide median pharmaceutical M&A value to revenue multiple 2011-2015

Median generic pharmaceutical merger and acquisition (M&A) value to revenue multiple worldwide from 2011 to 2015

by Statista Research Department, last edited Feb 2, 2016
Worldwide median pharmaceutical M&A value to revenue multiple 2011-2015 This statistic shows the median merger and acquisition (M&A) value to revenue multiple for generic pharmaceutical M&A deals worldwide from 2011 to 2015. In 2015, the median M&A value to revenue multiple was 5.1, almost double what it was in 2011.
Show more

Median generic pharmaceutical merger and acquisition (M&A) value to revenue multiple worldwide from 2011 to 2015

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.